aloe emodin has been researched along with Angiogenesis, Pathologic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, DQ; Chen, Q; Li, KT; Lin, HD; Tian, S; Yu, LH; Yu, TH | 1 |
Babykutty, S; Gopala, S; Nair, RS; Srinivas, P; Suboj, P; Valiyaparambil Gopi, DR | 1 |
Cárdenas, C; Medina, MA; Quesada, AR | 1 |
3 other study(ies) available for aloe emodin and Angiogenesis, Pathologic
Article | Year |
---|---|
Photodynamic Therapy Mediated by Aloe-Emodin Inhibited Angiogenesis and Cell Metastasis Through Activating MAPK Signaling Pathway on HUVECs.
Topics: Anthraquinones; Apoptosis; Cell Proliferation; Cytoskeleton; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Neoplasm Metastasis; Neovascularization, Pathologic; Photochemotherapy; Signal Transduction | 2018 |
Aloe emodin inhibits colon cancer cell migration/angiogenesis by downregulating MMP-2/9, RhoB and VEGF via reduced DNA binding activity of NF-κB.
Topics: Angiogenesis Inhibitors; Anthraquinones; Cell Movement; Cell Nucleus; Colonic Neoplasms; DNA; Down-Regulation; Endothelial Cells; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Neovascularization, Pathologic; NF-kappa B; Phosphorylation; Promoter Regions, Genetic; Protein Transport; rhoB GTP-Binding Protein; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2012 |
Evaluation of the anti-angiogenic effect of aloe-emodin.
Topics: Angiogenesis Inhibitors; Animals; Anthraquinones; Cattle; Cell Differentiation; Cell Line; Cell Movement; Cell Proliferation; Chickens; Dose-Response Relationship, Drug; Emodin; Endothelial Cells; Enzyme Inhibitors; Extracellular Matrix; Humans; Molecular Structure; Neovascularization, Pathologic; Urokinase-Type Plasminogen Activator | 2006 |